Hutch News
Results per Page:
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found